http://www.sbwire.com/press-releases/sbwire-95485.htm6/6/11Global...

http://www.sbwire.com/press-releases/sbwire-95485.htm

6/6/11

Global RNAi Market to Flourish as Extensive Research Floods In

With the advancement of research for RNAi-based therapeutics for multiple indications, the global RNAi market will witness a significant growth during 2010-2015, says RNCOS in its latest research study.

Noida, UP -- (SBWIRE) --06/06/2011 -- As per our new research report ?Global RNAi Market Analysis?, the global RNAi market is expected to witness stupendous growth rate in the coming years. Our study indicates that, the diversity of its applications has made RNAi an indispensable tool for both academic and industrial scientists interested in gene function characterization, signaling pathway analysis, and target validation.

We have identified some critical factors acting as a catalyst for the industry?s current and future growth outlook. The report reveals that, RNAi is already an established enabling biotechnology product platform and its usage in therapeutics and diagnostics may rival products like recombinant proteins or monoclonal antibodies in future. It is anticipated that, the global RNAi market will grow at a CAGR of around 28% during 2010-2015.

Besides, our study indicates that, presently at the nascent stages, the RNAi industry is gaining ground in the therapeutics arena, with its most promising application being high-throughput screening. The first of the approved RNAi-based drugs are expected to foray into the therapeutics market in 2013.

Further, the US and Europe together account for a lion's share in the global RNAi market. However, research and investments around the globe have spurred the industry performance to a great extent. The governments in various Asian countries, such as Japan, China, India, & Korea have made huge investments for the growth and development of RNAi research in their respective countries.